Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CEL-SCI Corp (NYSE MKT LLC:CVM)

2.18
Delayed Data
As of 3:55pm ET
 -0.0678 / -3.01%
Today’s Change
1.46
Today|||52-Week Range
13.55
+29.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$20.7M

Company Description

CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases. It engages in drug discovery, research, development and manufacturing of complex biological substances. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Contact Information

CEL-SCI Corp.
8229 Boone Boulevard
Vienna Virginia 22182
P:(703) 506-9460
Investor Relations:

Employees

Shareholders

Individual stakeholders8.28%
Other institutional5.74%
Mutual fund holders1.86%

Top Executives

Geert R. KerstenCEO, CFO, Director & Chief Accounting Officer
Patricia B. PrichepSecretary & Senior Vice President-Operations
Eyal TalorChief Scientific Officer
William JonesVice President-Quality Assurance
Daniel H. ZimmermanSenior VP-Research & Cellular Immunology